Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas

NCT05131386 is registered in ClinicalTrials.gov with Grupo Espanol de Investigacion en Sarcomas as lead sponsor.

NCT NCT05131386
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05131386 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Multicohort Trial of Trabectedin and Low-dose Radiation Therapy in Advanced/Metastatic Sarcomas
Lead sponsor
Grupo Espanol de Investigacion en Sarcomas
Phase
Phase 2
Overall status
Unknown status
Start date
May 28, 2021
Completion date
July 28, 2024
Enrollment
85 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

bone tumors, small round-cell sarcomas, soft tissue sarcoma